Biotreat 21

Company Overview

Snapshot

Founded in April 2010 by Roman Grinberg and Edward Shifrin, Biotreat 21 operates with 1–10 employees. The company is in the Pre-Funding stage and ceased operations in January 2022.

Business overview

Biotreat 21 is a Health Tech & Life Sciences company focused on developing a skin regeneration cream. Its core technology involves a disinfectant spray and a natural healing ointment designed to rapidly heal wounds by utilizing the individual's immune system. The product aims to be antiseptic, decrease inflammation, minimize irritation and pain, and improve skin renewal. Initial trials have shown the cream's potential to erase scars and heal severe diabetic ulcers, serving patients in the healthcare sector.

Strategic signal

In July 2016, news highlighted Biotreat 21's "Wonder Cream" for its ability to rapidly heal wounds. This signal indicated early validation of the company's innovative approach to skin regeneration, suggesting potential for significant impact in dermatology and wound care by offering a novel treatment for various skin conditions.

Company Intelligence Q&A

What is Biotreat 21's primary product?

Biotreat 21 has invented a cream intended to completely regrow damaged skin by utilizing the individual's own immune system. It is composed of a disinfectant spray and a natural healing ointment.

When was Biotreat 21 founded?

Biotreat 21 was founded in April 2010.

Who are the founders of Biotreat 21?

Roman Grinberg and Edward Shifrin are the co-founders of Biotreat 21.

What markets does Biotreat 21 target?

Biotreat 21 targets geomarkets including Russia and Israel.

What is the current operational status of Biotreat 21?

Biotreat 21 ceased to operate in January 2022.